Covered recipient · General Payments record
LISA CHRISTINA ORESCHAK
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$554.01
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $337.41 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $89.33 | 4 |
| ABBVIE INC. | $49.90 | 2 |
| Novo Nordisk AS | $42.88 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.33 | 1 |
| BECTON, DICKINSON AND COMPANY | $27.50 | 1 |
| Daiichi Sankyo Inc. | $26.13 | 1 |
| PFIZER INC. | $18.98 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.44 | 1 |
| Medtronic, Inc. | $18.39 | 1 |
| GlaxoSmithKline, LLC. | $13.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.74 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107767040 | CMS |
| ABBVIE INC. | $31.16 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107767042 | CMS |
| Amgen Inc. | $22.47 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117646049 | CMS |
| Amgen Inc. | $22.91 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117344058 | CMS |
| Amgen Inc. | $19.33 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117344056 | CMS |
| Amgen Inc. | $24.62 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117344054 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $18.44 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086331068 | CMS |
| Becton, Dickinson and Company | $27.50 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127619360 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.33 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117951814 | CMS |
| Daiichi Sankyo Inc. | $26.13 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089464858 | CMS |
| GlaxoSmithKline, LLC. | $13.53 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116016918 | CMS |
| Medtronic, Inc. | $18.39 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116929958 | CMS |
| Novo Nordisk Inc | $19.77 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100488773 | CMS |
| Novo Nordisk Inc | $23.11 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100276680 | CMS |
| PFIZER INC. | $18.98 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131074672 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.